Season 9, Episode 1 - Treating PBC: Alkaline Phosphatase response or improvement in liver stiffness?

This episode shifts the focus from symptoms and quality of life to biochemical and imaging-based endpoints in primary biliary cholangitis (PBC). Experts explore the relevance of alkaline phosphatase response, non-invasive fibrosis assessment, and composite scores like GLOBE and UK-PBC. Are these markers enough in the era of second-line therapies? Tune in for insights into trial design, drug approval, and future directions.

Faculty: Marco Carbone (Moderator), Christophe Hézode (Gilead Representative), Marwan Sleiman (Ipsen representative)

This EASL Studio is supported by Ipsen and Gilead Sciences Europe Ltd.